Andrew John Hugh MacIntyre Sims insider trades

Open-market stock purchases and sales by Andrew John Hugh MacIntyre Sims, Chief Financial Officer at Cerenome, Inc, from SEC Form 4 filings since Feb 6, 2020.

Track record: 100% of 7 scored buys are up 5% or more since purchase, averaging +140%.

Recent trades

DateStockTradeValue
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Oct 1, 2026CNSY Cerenome, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jul 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
May 14, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Apr 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Apr 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Feb 25, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Feb 25, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Jan 1, 2026PSTV Plus Therapeutics, IncBought (not open market)—
Nov 4, 2025PSTV Plus Therapeutics, IncBought$10.2K

Companies traded

  • CNSY Cerenome, Inc: other filings, last Oct 1, 2026
  • PSTV Plus Therapeutics, Inc: 9 buys, last Jul 1, 2026

Get free alerts when Andrew John Hugh MacIntyre Sims files a new trade →